4SC AG (FSE: VSC)

https://www.4sc.com

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that target key indications in cancer with high unmet medical needs. 4SC’s pipeline is protected by a comprehensive portfolio of patents and currently comprises one drug candidate in clinical development: Kinselby – resminostat. 4SC aims to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies and/or the eventual marketing and sales of approved drugs in select territories by 4SC itself. 4SC is headquartered in Planegg-Martinsried near Munich, Germany. The Company had 16 employees as of 30 June 2023 and is listed on the Prime Standard of the Frankfurt Stock Exchange (FSE Prime Standard: VSC; ISIN: DE000A3E5C40). *

	Start	1997-01-01 established_pre
	Industry	resminostat (4SC-201, Kinselby)
	Person	Loveridge, Jason (4SC 201609– CEO)
	Person 2	Doppler, Clemens (3i Germany 2007 Director Healthcare Team)

	Street	22 Fraunhoferstr.
	City	82152 Martinsried
	Tel	+49-89-700763-0
		Address record changed: 2022-09-17

Basic data	Employees	B: 11 to 50 (2019-12-31)
	Currency	EUR
	Annual sales	2,196,000 (revenue, consolidated (2019) 2019-12-31)
	Profit	-13,962,000 (2019-12-31)
	Cash	31,727,000 (2019-12-31)

		* Document for »About Section«: 4SC AG. (9/27/23). "Press Release: 4SC Receives Orphan Drug Designation (ODD) for Resminostat (Kinselby) in CTCL from the US FDA". Planegg-Martinsried.

		Record changed: 2023-12-30

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for 4SC (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)